UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):  December 4, 2012

Medytox Solutions, Inc.
(Exact Name of Registrant as Specified in Its Charter)

Nevada
(State or Other Jurisdiction of Incorporation)

000-54346

54-2156042

(Commission File Number)

(I.R.S. Employer Identification No.)


400 S. Australian Avenue, Suite 800, West Palm Beach, Florida

33401

(Address of Principal Executive Offices)

(Zip Code)


(561) 855-1626

(Registrant’s Telephone Number, Including Area Code)


 

(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Section 1 Registrant's Business and Operations

Item 1.01.  Entering into a Material Definitive Agreement

As previously reported in the Form 8-K filed on May 21, 2012, on May 14, 2012, Medytox Solutions, Inc. ("Medytox") borrowed $550,000 from TCA Global Credit Master Fund, LP ("TCA") pursuant to the terms of the Senior Secured Revolving Credit Facility Agreement, dated as of April 30, 2012, among Medytox, Medytox Medical Marketing & Sales, Inc., Medytox Diagnostics, Inc., PB Laboratories, LLC and TCA.  As further previously reported in the Form 8-K filed on August 15, 2012, on August 8, 2012, Medytox borrowed an additional $525,000 from TCA pursuant to the terms of Amendment No. 1 to Senior Secured Revolving Credit Facility Agreement, dated as of July 31, 2012 (as so amended, the "Credit Agreement").  

On December 4, 2012, Medytox borrowed an additional $650,000 from TCA pursuant to the terms of Amendment No. 2 to Senior Secured Revolving Credit Facility Agreement, dated as of October 31, 2012 ("Amendment No. 2").  These additional funds shall be used in accordance with management's discretion.

Amendment No. 2 effected certain changes to the terms of the Credit Agreement:

·

the revolving loan commitment was increased from $1,100,000 to $1,725,000 and is subject to further increase up to a maximum of $15,000,000 in TCA's sole discretion;

·

the maturity date of the loan was extended to September 3, 2013 from the previous maturity of February 8, 2013 (subject to TCA's continuing ability to call the loan upon 60 days written notice); and

·

a covenant was added to require that any subsidiary that is formed, acquired or otherwise becomes a subsidiary must guarantee the loan and pledge substantially all of its assets as security for the loan.

Medytox paid certain fees to TCA, as set forth in Amendment No. 2.  Medytox also issued to TCA 10,000 shares of its restricted common stock as a fee for corporate advisory and investment banking services provided by TCA.

In connection with Amendment No. 2, Medytox executed an Amended and Restated Revolving Promissory Note in the amount of $1,725,000.  Except as provided in Amendment No. 2, the terms of the Credit Agreement remain in full force and effect.

There are no material relationships between Medytox or any of its affiliates and TCA, other than with respect to the Credit Agreement and Amendment No. 2.  

The foregoing is qualified in its entirety by reference to (i) Amendment No. 2, a copy of which is filed herewith as Exhibit 10.1, and (ii) the Amended and Restated Revolving Promissory Note, a copy of which is filed herewith as Exhibit 10.2.



2


Section 2 – Financial Information

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The information set forth above in Item 1.01 is incorporated by reference.

Section 9 – Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits

(d)  Exhibits

Exhibit Number

Description

10.1

Amendment No. 2 to Senior Secured Revolving Credit Facility Agreement, dated as of October 31, 2012, among Medytox Solutions, Inc., Medytox Medical Marketing & Sales, Inc., Medytox Diagnostics, Inc., PB Laboratories, LLC and TCA Global Credit Master Fund, LP

10.2

Amended and Restated Revolving Promissory Note, dated October 31,  2012, issued by Medytox Solutions, Inc. to TCA Global Credit Master Fund, LP



3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  December 17, 2012

MEDYTOX SOLUTIONS, INC.


/s/ William G. Forhan

William G. Forhan,
CEO and Chairman
(principal executive officer)


 



4


EXHIBIT INDEX

Exhibit Number

Description

10.1

Amendment No. 2 to Senior Secured Revolving Credit Facility Agreement, dated as of October 31, 2012, among Medytox Solutions, Inc., Medytox Medical Marketing & Sales, Inc., Medytox Diagnostics, Inc., PB Laboratories, LLC and TCA Global Credit Master Fund, LP

10.2

Amended and Restated Revolving Promissory Note, dated October 31,  2012, issued by Medytox Solutions, Inc. to TCA Global Credit Master Fund, LP














AMENDMENT NO. 2


TO


SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENTIN THE AMOUNT OF US$15,000,000


BY AND AMONG


MEDYTOX SOLUTIONS, INC.,as Borrower,


MEDYTOX MEDICAL MARKETING & SALES, INC.,MEDYTOX DIAGNOSTICS, INC., andPB LABORATORIES, LLCas Joint and Several Guarantors,


AND


TCA GLOBAL CREDIT MASTER FUND, LP,as Lender






October 31, 2012




{25398566;2}0



AMENDMENT NO. 2 TO

SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENT


THIS AMENDMENT NO. 2 TO SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENT (this Amendment ) is made as of the 31st day of October, 2012, by and among (i) MEDYTOX SOLUTIONS, INC., a corporation incorporated under the laws of the State of Nevada (the Borrower ), (ii) MEDYTOX MEDICAL MARKETING & SALES, INC., a corporation incorporated under the laws of the State of Florida, MEDYTOX DIAGNOSTICS, INC., a corporation incorporated under the laws of the State of Florida, and PB LABORATORIES, LLC, a limited liability company organized and existing under the laws of the State of Florida, as joint and several guarantors (each a Guarantor and collectively the Guarantors and together with Borrower, the Credit Parties ) and (iii) TCA GLOBAL CREDIT MASTER FUND, LP, a limited partnership organized and existing under the laws of the Cayman Islands (the Lender ).

WITNESSETH

WHEREAS, the Credit Parties and the Lender have entered into that certain senior secured revolving credit facility agreement, dated as of April 30, 2012 (the Credit Agreement ), pursuant to which the Lender agreed to make available to the Borrower a secured revolving loan in the amount of Four Million United States Dollars (US$4,000,000), subject to the terms and conditions therein contained, and of this amount, the Lender made an initial principal advance of Five Hundred Fifty Thousand United States Dollars (US$550,000) to the Borrower;

WHEREAS, the Credit Parties have entered into that certain amendment no. 1 to the Credit Agreement, dated as of July 31, 2012 ( Amendment No. 1 ), pursuant to which the Lender advanced an additional principal amount of Five Hundred Twenty Five Thousand United States Dollars (US$525,000) to the Borrower;

WHEREAS, as of the date hereof, a total aggregate principal amount of One Million Seventy Five Thousand United States Dollars (US$1,075,000) of principal plus applicable interest are outstanding;

WHEREAS, in connection with this Amendment, the Borrower has requested and the Lender has agreed to advance an additional principal amount of Six Hundred Fifty Thousand United States Dollars (US$650,000) to the Borrower; and

WHEREAS, the parties to this Amendment desire to further amend the Credit Agreement, as previously amended by Amendment No. 1 (as previously amended thereby, the Amended Credit Agreement ), as set forth herein.

NOW, THEREFORE, in consideration of the premises set forth above, the covenants and agreements hereinafter set forth, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

1. Defined Terms .  Unless otherwise defined herein, the capitalized terms used herein shall have the meanings assigned to such terms in the Amended Credit Agreement.

 



1



2. Amendment of the Amended Credit Agreement .  Subject to the terms and conditions of this Amendment, the Amended Credit Agreement is hereby further amended and supplemented as follows:

(a)

all references to the Senior Secured Revolving Credit Facility Agreement or the Agreement contained in the Amended Credit Agreement shall be deemed to refer to the Amended Credit Agreement as further amended hereby;

(b)

The definition of Revolving Loan Commitment shall be deleted in its entirety and shall be replaced with the following:

Revolving Loan Commitment shall mean One Million Seven Hundred Twenty Five Thousand and No/100 United States Dollars (US$1,725,000), and in the event Borrower requests and Lender agrees to increase the Revolving Loan Commitment pursuant to Section 2.1(b) , such aggregate additional amount up to Fifteen Million and No/100 United States Dollars ($15,000,000).

(c)

Section 2.1(b) shall be deleted in its entirety and shall be replaced with the following:

Increase to Revolving Loan Commitment .  Borrower may request and the Lender may, in its sole and absolute discretion (employing substantially the same analysis and metrics the Lender used when determining to originally extend credit hereunder), agree to increase the Revolving Loan Commitment to such additional amounts and at such times as may be determined by the Lender in its sole discretion, up to an amount not to exceed Fifteen Million and No/100 United States Dollars (US$15,000,000); and Lender, in its sole discretion, may, but in any event, is not required to, make available such additional Revolving Loan Commitment increases to Borrower provided the following conditions have been satisfied, in Lender s sole and absolute discretion: (i) no Event of Default shall have occurred and be continuing or result from the applicable increase of the Revolving Loan Commitment; (ii) Borrower shall have executed and delivered a new or revised Revolving Note; (iii) after giving effect to such increase, the amount of the aggregate outstanding principal balance of all Revolving Loans shall not be in excess of the Revolving Loan Availability; and (iv) Lender shall have reviewed and accepted the amount and type of Accounts that are to be Eligible Accounts.

(d)

Section 9.1 shall be amended by deleting the word "and" at the end of clause (i), adding ";and" at the end of clause (j) and adding the following:

(k) Funded Indebtedness represented by the Secured Promissory Note dated October 31, 2012, payable by Medytox Diagnostics, Inc., in favor of MaryluVillasenor Hall in the amount of $150,000.

(e)



2



Section 9.3 shall be amended by deleting the word "or" at the end of clause (f), adding "; or" at the end of clause (g) and adding the following:

(h) The 49.5% ownership interest in PB Laboratories, LLC purchased by Medytox Diagnostics, Inc. from MaryluVillasenor Hall pursuant to the Membership Interest Purchase Agreement, dated as of October 31, 2012.

(f)

Section 10.19 shall be deleted in its entirety and shall be replaced with the following:

In the event that the Borrower files a registration statement with respect to its Common Stock with the SEC (other than a registration statement on Form S-4 or S-8 or any successor form thereto) after the Closing Date but before the Lender sells all the Commitment Shares, Second Tranche Commitment Shares or the Third Tranche Commitment Shares, the Commitment Shares, Second Tranche Commitment Shares and the Third Tranche Commitment Shares held by the Lender at such time of filing such registration statement shall be registered pursuant to such registration statement.

(g)

Section 10.21 shall be amended by deleting the word "and" at the end of clause (i), adding "; and" at the end of clause (ii) and adding the following:

(iii) any Subsidiary which is formed or acquired or otherwise becomes a Subsidiary of the Borrower following the date hereof, within ten (10) Business Days of such event, to become an additional Credit Party hereto, including, but not limited to, causing such party to execute counterparts to this Agreement and to execute a Guarantee Agreement and a Security Agreement in the forms attached hereto as Exhibit D and Exhibit G-2.

3. Use of Proceeds .  Notwithstanding anything which may be contained in the Amended Credit Agreement to the contrary, the $650,000 advance being made in connection with this Amendment shall be used in accordance with management s discretion.

4. Renewal of Revolving Loan .  Pursuant to Section 2.3 of the Amended Credit Agreement, by its execution hereof, the Borrower hereby provides written notice to Lender of Borrower s election to renew the Revolving Loan Commitment and extend the Revolving Loan Maturity Date for an additional six (6) month period commencing on the date hereof and terminating on September 3, 2013 (subject to the terms and conditions of the Amended Credit Agreement, as amended hereby) and, by its execution hereof, the Lender hereby consents and agrees to such renewal and extension.

5. Cancellation of Existing Promissory Note .  By the Credit Parties execution and delivery to the Lender of the Amended and Restated Promissory Note (as hereinafter defined), that certain amended and restated promissory note originally issued by the Borrower in favor of the Lender, dated July 31, 2012, in the original principal amount of One



3



Million One Hundred Thousand United States Dollars (US$1,100,000) shall be hereby immediately and irrevocably cancelled without further action on the part of the Lender or the Credit Parties.

6. Representations and Warranties of the Credit Parties .  The Credit Parties each represent and warrant to the Lender that immediately after giving effect to this Amendment, the representations and warranties of each Credit Party set forth in the Amended Credit Agreement, as amended hereby, are true and correct in all material respects and no Default or Event of Default shall have occurred and be continuing.  In addition, the Credit Parties hereby make the same representations and warranties to the Lender as those provided in Section 7 of the Amended Credit Agreement with regard to the Third Tranche Commitment Shares (as hereafter defined), in addition to the representations and warranties pertaining to the Commitment Shares, the Second Tranche Commitment Shares and the Revolving Notes.

7. Representations and Warranties of Lender .  Lender hereby makes the same representations and warranties to the Credit Parties as those provided in Section 8 of the Amended Credit Agreement with regard to the Third Tranche Commitment Shares in addition to the representations and warranties pertaining to the Commitment Shares, the Second Tranche Commitment Shares and the Revolving Notes.

8. No Defaults .  Each Credit Party hereby represents and warrants that as of the date hereof there exists no Event of Default or any condition which, with the giving of notice or passage of time, or both, would constitute an Event of Default.

9. Covenants .  Each Credit Party hereby reaffirms that each has duly performed and observed the covenants and undertakings set forth in the Amended Credit Agreement and each Loan Document, and each covenants and undertakes to continue to duly perform and observe such covenants and undertakings, as amended hereby, so long as the Amended Credit Agreement, as amended hereby, shall remain in effect.

10. No Other Amendment .  All other terms and conditions of the Amended Credit Agreement shall remain in full force and effect and the Amended Credit Agreement shall be read and construed as if the terms of this Amendment were included therein by way of addition or substitution, as the case may be.

11. Third Tranche Commitment Shares .  The Borrower hereby agrees to pay to the Lender, on the date hereof, a fee for corporate advisory and investment banking services by issuing to the Lender that number of shares of the Borrower s common stock (the Third Tranche Commitment Shares ) equal to a dollar amount of Twenty Five Thousand United States Dollars (US$25,000) (the Third Tranche Share Value ).  It is hereby agreed that, as of the date hereof, the Third Tranche Share Value shall be fully satisfied by the delivery of Ten Thousand (10,000) shares of the Borrower s common stock to the Lender.  The Borrower shall instruct its transfer agent to issue certificates representing the Third Tranche Commitment Shares issuable to the Lender immediately upon the Borrower s execution of this Amendment, and shall cause its transfer agent to deliver such certificates to the Lender within three (3) Business Days of the date hereof.  In the event such certificates representing the Third Tranche Commitment Shares issuable hereunder shall not be delivered to the Lender within said three (3) Business Day period, the Borrower shall be in immediate default under this Amendment, the Amended Credit Agreement and the Loan Documents.  The Third Tranche Commitment Shares, when issued,



4



shall be deemed to be validly issued, fully paid, and non-assessable shares of the Borrower s common stock.  The Third Tranche Commitment Shares are and shall be deemed fully earned in connection with the corporate advisory and investment banking services provided by the Lender to the Borrower as of the date hereof.  

12. Adjustment to Third Tranche Commitment Shares .  It is the intention of the Lender and the Borrower that by the Twelve Month Valuation Date the Lender shall have generated net proceeds from the sale of the Third Tranche Commitment Shares equal to the Third Tranche Share Value.  The Lender shall have the right to sell the Third Tranche Commitment Shares at any time in accordance with applicable securities laws, but in any event, not during the six (6) month period following the execution of this Amendment (the Third Tranche Anti-Dilution Period ), providedthat Lender agrees to use its good faith efforts to sell the Third Tranche Commitment Shares after the applicable restrictive holding period applicable thereto has expired (and provided the restrictive legends thereon have been removed and the Third Tranche Commitment Shares are otherwise freely tradable), in such amounts as reasonably practicable given then existing market conditions, in Lender s discretion, with the intention of selling the Third Tranche Commitment Shares as soon as reasonably practicable following the expiration of the restricted holding period and removal of restrictive legends on such Third Tranche Commitment Shares.  At any time the Lender may elect after the Twelve Month Valuation Date (or prior to such Twelve Month Valuation Date, if Lender has sold all Third Tranche Commitment Shares prior to such Twelve Month Valuation Date), the Lender may deliver to the Borrower a Sale Reconciliation.  If, as of the date of the delivery by Lender of the Sale Reconciliation, the Lender has not realized net proceeds from the sale of such Third Tranche Commitment Shares equal to at least the Third Tranche Share Value, as shown on the Sale Reconciliation, then the Borrower shall immediately take all required action necessary or required in order to cause the issuance of additional shares of Common Stock to the Lender in an amount sufficient such that, when sold and the net proceeds thereof are added to the net proceeds from the sale of any of the previously issued and sold Third Tranche Commitment Shares, the Lender shall have received total net funds equal to the Third Tranche Share Value.  If additional shares of Common Stock are issued pursuant to the immediately preceding sentence, and after the sale of such additional issued shares of Common Stock, the Lender still has not received net proceeds equal to at least the Third Tranche Share Value, then the Borrower shall again be required to immediately take all required action necessary or required in order to cause the issuance of additional shares of Common Stock to the Lender as contemplated above, and such additional issuances shall continue until the Lender has received net proceeds from the sale of such Common Stock equal to the Third Tranche Share Value.  In the event the Lender receives net proceeds from the sale of Third Tranche Commitment Shares equal to the Third Tranche Share Value, and the Lender still has Third Tranche Commitment Shares remaining to be sold, the Lender shall return all such remaining Third Tranche Commitment Shares to the Borrower.  In the event additional Common Stock is required to be issued as outlined above, the Borrower shall instruct its transfer agent to issue certificates representing such additional shares of Common Stock to the Lender immediately subsequent to the Lender s notification to the Company that additional shares of Common Stock are issuable hereunder, and the Borrower shall in any event cause its transfer agent to deliver such certificates to Lender within three (3) Business Days following the date Lender notifies the Borrower that additional shares of Common Stock are to be issued hereunder.  In the event such certificates representing such additional shares of Common Stock issuable hereunder shall not be delivered to the Lender within said three (3) Business Day period, same shall be an immediate default under this Amendment, the Amended Credit Agreement and the Loan Documents.  Notwithstanding



5



anything contained herein to the contrary, at any time during the Third Tranche Anti-Dilution Period, but not thereafter (unless agreed by the Lender), the Borrower shall have the right, at any time during such period, to redeem any Third Tranche Commitment Shares then in the Lender's possession for an amount payable by the Borrower to the Lender in United States funds equal to the Third Tranche Share Value, less any net cash proceeds received by the Lender from any previous sales of Third Tranche Commitment Shares.  Notwithstanding anything which may be contained hereto to the contrary, at such time as the Third Tranche Commitment Shares are able to be sold in accordance with applicable securities laws and after the Third Tranche Anti-Dilution Period, the Borrower shall take all actions necessary or advisable to remove the restrictive legend from the share certificate(s) representing the Third Tranche Commitment Shares upon receipt of documentation from the Lender necessary to accomplish such removal.  Notwithstanding anything contained herein to the contrary, commencing immediately after the Borrower has redeemed all of the Commitment Shares and the Second Tranche Commitment Shares pursuant to Section 10.18 of the Amended Credit Agreement, and continuing each week thereafter, each week the Borrower shall redeem certain of the Third Tranche Commitment Shares then in the Lender s possession equal to Two Thousand Five Hundred United States Dollars (US$2,500) per week.  Upon Lender s receipt of such cash payment to redeem any Third Tranche Commitment Shares in accordance with this Section 11, the Lender shall return such amount of the Third Tranche Commitment Shares equal to the applicable fractional portion of the Third Tranche Share Value.  Final determination of the amount of Third Tranche Commitment Shares to be returned to the Borrower upon payment pursuant to this Section shall be determined by the Lender in its sole and absolute discretion.

13. Fees and Expenses .  The Borrower agrees to pay to the Lender, upon the execution hereof, (i) a commitment fee equal to Twenty Six Thousand United States Dollars (US$26,000), (ii) a legal fee equal to Two Thousand Five Hundred United States Dollars (US$2,500), (iii) a due diligence fee equal to Two Thousand Five Hundred United States Dollars (US$2,500), (iv) an asset monitoring fee equal to Two Thousand Five Hundred United States Dollars ($2,500), and (v) all costs and expenses of the Lender and Lender s counsel in connection with the preparation and execution of this Amendment, including, but not limited to, documentary stamp tax fees.

14. Conditions Precedent .  The effectiveness of this Amendment shall be expressly subject to the following conditions precedent:

(a)

Amendment .  Each Credit Party shall have executed and delivered to the Lender this Amendment;

(b)

Amended and Restated Promissory Note .  The Borrower shall have executed and delivered to the Lender an original amended and restated promissory note in the principal amount of One Million Seven Hundred Twenty Five Thousand and No/100 United States Dollars (US$1,725,000), dated as of the date of this Amendment, in the form attached hereto as Exhibit A;

(c)

Borrowing Base Certificate .  The Borrower shall have executed and delivered to the Lender a borrowing base certificate, dated as of the date of this Amendment, substantially in the form attached to the Credit Agreement as Exhibit A;

(d)



6


Closing Statement .  The Borrower shall have executed and delivered to the Lender a closing statement in form and substance satisfactory to the Lender;

(e)

Corporate Documents .  The Lender shall have received such evidence as it may require as to the authority of the officers or attorneys-in-fact executing this Amendment and such other corporate documents it may request, including, but not limited to, a unanimous written consent of the board of directors or managers and an officer s certificate of each Credit Party, in form and substance satisfactory to the Lender in its sole discretion;

(f)

Opinion of Counsel .  The Lender shall have received a customary opinion of the Credit Parties counsel, in form and substance satisfactory to the Lender in its sole discretion;

(g)

Search Results .  The Lender shall have received copies of UCC search reports dated such a date as is reasonably acceptable to Lender, listing all effective financing statements which name the Credit Parties and/or their subsidiaries, under their present name and any previous names, as debtors, together with copies of such financing statements;

(h)

Certificate of Good Standing .  The Lender shall have received a Certificate of Good Standing from the Secretary of State of the state of organization of each Credit Party, and each subsidiary thereof, evidencing the good standing thereof;

(i)

Fees Paid .  The Lender or its counsel shall have received payment in full of all fees and expenses due under this Amendment; and

(j)

No Event of Default .  The Lender shall be satisfied, and shall have received a certificate signed by a duly authorized officer of each Credit Party, dated as of the date hereof, that (i) no Event of Default or event which, with the passage of time, giving of notice or both would become an Event of Default have occurred and be continuing; and (ii) the representations and warranties of the Borrower contained in the Amended Credit Agreement, as amended and supplemented hereby, shall be true on and as of the date of this Amendment (except to the extent such representation or warranty expressly relates to an earlier date).

15. Execution in Counterparts .  This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.

16. Governing Law .  THIS AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEVADA.

17. Amendment Effective Date .  All references in any Loan Document to the Amended Credit Agreement on and after the date hereof shall be deemed to refer to the Amended Credit Agreement as further amended hereby, and the parties hereto agree that on and



7



after the date hereof, the Amended Credit Agreement, as further amended hereby, is in full force and effect.


[signatures pages follow]




8



IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by their duly authorized officers as of the date first above written.


BORROWER :



MEDYTOX SOLUTIONS, INC.



By:

/s/ William G. Forhan

Name:

William Forhan

Title:

Chief Executive Officer




LENDER :


TCA GLOBAL CREDIT MASTER FUND, LP


By:

TCA Global Credit Fund GP, Ltd.

Its:

General Partner



By:

/s/Robert Press

Name:

Robert Press

Title:

Director













[ signature page 1 of 2 ]



9



CONSENT AND AGREEMENT

The undersigned, referred to in the foregoing amendment no. 2 to the senior secured revolving credit facility agreement (the Amendment ) as a guarantor, hereby consents and agrees to said Amendment and to the payment of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to be performed by it pursuant to or in connection with said Amendment.


GUARANTORS :



MEDYTOX MEDICAL MARKETING & SALES, INC.



By:

/s/ Seamus Lagan

Name:

Seamus Lagan

Title:

CEO



MEDYTOX DIAGNOSTICS, INC.



By:

/s/ Seamus Lagan

Name:

Seamus Lagan

Title:

CEO


PB LABORATORIES, LLC



By:

/s/ Sharon Hollis

Name:

Sharon Hollis

Title:

CEO









[ signature page 2 of 2 ]



10



EXHIBIT A





AMENDED AND RESTATED PROMISSORY NOTE





















11


THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.  THE SECURITIES HAVE BEEN ACQUIRED SOLELY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD RESALE AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, ACCEPTABLE TO BORROWER S COUNSEL, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.


AMENDED AND RESTATED

REVOLVING PROMISSORY NOTE


Issuance Date: October 31, 2012

US$1,725,000


Effective Date: December 3, 2012



FOR VALUE RECEIVED, MEDYTOX SOLUTIONS, INC., a Nevada corporation, whose address is 400 South Australian Avenue, Suite 800, West Palm Beach, Florida 33401 (the Borrower ), promises to pay to the order of TCA GLOBAL CREDIT MASTER FUND, LP (hereinafter, together with any holder hereof, the Lender ), whose address is 1404 Rodman Street, Hollywood, Florida 33020, on or before September 3, 2013 or such later date as agreed upon after the date hereof in a signed writing by the Lender (the Revolving Loan Maturity Date ), the lesser of: (i) One Million Seven Hundred Twenty Five Thousand and No/100 United States Dollars (US$1,725,000); or (ii) the aggregate principal amount outstanding under and pursuant to that certain senior secured revolving credit facility agreement, dated as of April 30, 2012, as amended by amendment no. 1 thereto, dated July 31, 2012, and as further amended by amendment no. 2 thereto, dated as of October 31, 2012, executed by and among the Borrower, certain subsidiaries of the Borrower, and the Lender (as amended, supplemented or modified from time to time, the Credit Agreement ),together with interest (computed on the actual number of days elapsed on the basis of a 360 day year) on the aggregate principal amount outstanding from time to time. Capitalized words and phrases not otherwise defined herein shall have the meanings assigned thereto in the Credit Agreement.


This Amended and Restated Revolving Promissory Note (the Note ) amends, restates and replaces, in its entirely, that certain Amended and Restated Revolving Promissory Note, dated July 31, 2012, issued by the Borrower in favor of the Lender, pursuant to which the Borrower promised to pay the principal amount of $1,100,000, subject to the terms and conditions therein contained, to the Lender.  


This Note evidences a portion of the aggregate Revolving Loans being advanced and which may be advanced to the Borrower under and pursuant to the Credit Agreement, to which reference is hereby made for a statement of the terms and conditions under which the Revolving Loan Maturity Date or any payment hereon may be accelerated. The holder of this Note is entitled to all of the benefits and security provided for in the Loan Documents of even date herewith.  This Note shall be repaid by Borrower on the Revolving Loan Maturity Date, unless payable sooner pursuant to the provisions of the Credit Agreement.


1


Principal and interest shall be paid to Lender as set forth in the Credit Agreement, or at such other place as the holder of this Note shall designate in writing to the Borrower. Each Revolving Loan made by Lender, and all payments on account of the principal and interest thereof shall be recorded on the books and records of Lender and the principal balance as shown on such books and records, or any copy thereof certified by an officer of Lender, shall be rebuttable presumptive evidence of the principal amount owing hereunder.


Except for such notices as may be required under the terms of the Credit Agreement, the Borrower waives presentment, demand, notice, protest, and all other demands, ornotices, in connection with the delivery, acceptance, performance, default, or enforcement of this Note, and assents to any extension or postponement of the time of payment or any other indulgence.


Borrower shall be solely responsible for the payment of any and all documentary stamps and other taxes applicable to the full face amount of this Note.


The Revolving Loan evidenced hereby has been made and/or issued and this Note has been delivered at Lender s main office set forth above.  This Note shall be governed and construed in accordance with the laws of the State of Nevada, in which state it shall be performed, and shall be binding upon Borrower and its legal representatives, successors, and assigns.  Wherever possible, each provision of the Credit Agreement and this Note shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of the Credit Agreement or this Note shall be prohibited by or be invalid under such law, such provision shall be severable, and be ineffective to the extent of such prohibition or invalidity, without invalidating the remaining provisions of the Credit Agreement or this Note.


Nothing herein contained, nor in any instrument or transaction relating hereto, shall be construed or so operate as to require the Borrower, or any person liable for the payment of this Note, to pay interest in an amount or at a rate greater than the highest rate permissible under applicable law. By acceptance hereof, Lender hereby warrants and represents to Borrower that Lender has no intention of charging a usurious rate of interest. Should any interest or other charges paid by Borrower, or any parties liable for the payments made pursuant to this Note, result in the computation or earning of interest in excess of the highest rate permissible under applicable law, any and all such excess shall be and the same is hereby waived by the holder hereof. Lender shall make adjustments in the Note or Credit Agreement, as applicable, as necessary to ensure that Borrower will not be required to pay further interest in excess of the amount permitted by Nevada law. All such excess shall be automatically credited against and in reduction of the outstanding principal balance. Any portion of such excess which exceeds the outstanding principal balance shall be paid by the holder hereof to the Borrower and any parties liable for the payment of this Note, it being the intent of the parties hereto that under no circumstances shall Borrower, or any party liable for the payments hereunder, be required to pay interest in excess of the highest rate permissible under applicable law.


Notice shall be given to each party at the address indicated in the preamble hereto or at such other address as provided to the other party in writing.




[signature page follows ]


2

 

INWITNESSWHEREOF, the Borrower has executed this Note as of the date set forth above.




BORROWER :


MEDYTOX SOLUTIONS, INC.



By: /s/ William G. Forhan

 

Name: William G. Forhan

Title: Chief Executive Officer






























[Signature Page 1 to Amended and Restated Revolving Promissory Note]

 

3


 

CONSENT AND AGREEMENT


The undersigned, referred to in the foregoing amended and restated revolving promissory note as a guarantor, hereby consents and agrees to said amended and restated revolving promissory note and to the payment of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to be performed by it pursuant to or in connection with said amended and restated revolving promissory note to the same extent as if the undersigned were a party to said amended and restated revolving promissory note.


GUARANTORS :



MEDYTOX MEDICAL MARKETING & SALES, INC.



By:

/s/ William G. Forhan

Name:

William G. Forhan

Title:

Secretary



MEDYTOX DIAGNOSTICS, INC.



By:

/s/ William G. Forhan

Name:

William G. Forhan

Title:

Secretary


PB LABORATORIES, LLC



By:

/s/ Sharon Hollis

Name:

Sharon Hollis

Title:

CEO







[Signature Page 2 to Amended and Restated Revolving Promissory Note]



4